Scholarly Index
Mônica R. Gadelha
Universidade Federal do Rio de Janeiro; 11,646 total citations; 337 total publications; best world rank #3
Universidade Federal do Rio de Janeiro
11,646Total citations
337Total publications
58H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Pituitary Gland Disorders and Treatments | Lifetime | 146 | BR 1 | 99.02 |
| Adrenal and Paraganglionic Tumors | Lifetime | 132 | BR 1 | 98.69 |
| Growth Hormone and Insulin-like Growth Factors | Lifetime | 273 | BR 2 | 98.52 |
| Neuroendocrine Tumor Research Advances | Lifetime | 603 | BR 1 | 98.00 |
| Adrenal Hormones and Disorders | Lifetime | 295 | BR 3 | 96.93 |
| Ophthalmology and Eye Disorders | Lifetime | 606 | BR 8 | 95.45 |
| Growth Hormone and Insulin-like Growth Factors | 2021-2025 | 3 | BR 1 | 99.61 |
| Pituitary Gland Disorders and Treatments | 2021-2025 | 6 | BR 1 | 99.72 |
| Adrenal and Paraganglionic Tumors | 2021-2025 | 12 | BR 1 | 99.15 |
| Adrenal Hormones and Disorders | 2021-2025 | 9 | BR 1 | 98.90 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 188 | BR 1 | 95.65 |
| Glioma Diagnosis and Treatment | 2021-2025 | 490 | BR 1 | 95.84 |
| Ophthalmology and Eye Disorders | 2021-2025 | 305 | BR 4 | 84.17 |
| Chromatin Remodeling and Cancer | 2021-2025 | 605 | BR 4 | 63.38 |
| Hedgehog Signaling Pathway Studies | 2021-2025 | 595 | BR 8 | 57.88 |